610 Safety and Efficacy of Lenabasum in Refractory Skin-Predominant Dermatomyositis Subjects Treated on an Open-Label Extension of Trial JBT101-DM-001
Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.686
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Elsevier BV